Cholelithiasis in a newborn following treatment with the somatostatin analogue octreotide.
We report the case of a newborn infant affected by congenital hyperinsulinism who developed cholelithiasis associated with cholestatic jaundice following treatment with octreotide, a somatostatin analogue.